**Correction to:** *Translational Psychiatry* (2015) **5**, e553; doi:[10.1038/tp.2015.47](/doifinder/10.1038/tp.2015.47); published online 21 April 2015

Following publication, the authors identified an error in the meta-analysis of ISPC, AMPS and STAR\*D data. The error resulted from a failure to correctly harmonize alleles at some SNPs prior to meta-analyzing results from the three studies. This error had no impact on the primary analysis, which focused on the ISPC data alone (Table 2, Figure 1), but resulted in several incorrect signals being listed in [Table 3](#tbl3){ref-type="table"} (meta-analysis results). The corrected [Table 3](#tbl3){ref-type="table"} is shown below, along with a corrected [Figure 2](#fig2){ref-type="fig"} (Manhattan plot of the meta-analysis). A new [Supplementary File](#sup1){ref-type="supplementary-material"} is available online. The corrections to the article are described below.

In the Abstract, the sentence 'Top association results in the meta-analysis of response included single-nucleotide polymorphisms (SNPs) in the *HPRTP4* (hypoxanthine phosphoribosyltransferase pseudogene 4)/VSTM5 (V-set and transmembrane domain containing 5) region, which approached genome-wide significance (*P*=5.03E−08) and SNPs 5′ upstream of the neuregulin-1 gene, *NRG1* (*P*=1.20E−06)\' should read 'The top association result in the meta-analysis of response represents SNPs 5′ upstream of the neuregulin-1 gene, *NRG1* (*P*=1.20E−06).\'

In the Results section, the following sentence should not have been included in the article: 'In the meta-analysis of response, one SNP approached genome-wide significance ([Table 3](#tbl3){ref-type="table"}; rs2456568, *P*=5.0E−08). This SNP lies 3′ downstream of the pseudogene *HPRTP4*, with other SNPs in this region with *P*-values \<10^−6^ being located 5′ upstream of the gene *VSTM5* (V-set and transmembrane domain containing 5; [Supplementary Figure S4](#sup1){ref-type="supplementary-material"}).\' The subsequent sentence should not have begun with 'Other\' the corrected sentence is 'Notable top association regions for response include the 5′ upstream region of the neuregulin gene, *NRG1* ([Figure 2b](#fig2){ref-type="fig"} and [Supplementary Figure S4](#sup1){ref-type="supplementary-material"}).\'

Also in the Results section, the following sentence should have appeared with the two changes shown in square brackets: 'Although the observed associations are not significant after correction for multiple testing of SNPs selected for these replication analyses, we observed marginally significant evidence of association of SNP rs11624702 in *MDGA2* (MAM domain containing glycosylphosphatidylinositol anchor 2) with response in the ISPC alone (*P*=0.061) and \['and\' should read 'but not\'\] in the combined ISPC-AMPS-STAR\*D meta-analysis (*P*=0.029) \['0.029\' should read '0.36\'\], with the minor allele being associated with lower odds of response (that is, worse clinical outcomes)\'.

In the Discussion section, the statement 'A meta-analysis that included the ISPC, PGRN-AMPS and STAR\*D data revealed a SNP in the region of the HPRTP4 and VSTM5 genes that approached genome-wide significance for association with response (p=5.0E-08). Replication of this association signal is warranted, prior to further functional follow-up. Moreover, several of the top association signals that did not achieve genome-wide significance were in genes of biological interest, most notably NRG1, which merits further investigation into their potential role in depression and antidepressant response.\' should read 'A meta-analysis that included the ISPC, PGRN-AMPS and STAR\*D data revealed several association signals that did not achieve genome-wide significance but were in genes of biological interest, most notably NRG1, which merits further investigation into their potential role in depression and antidepressant response.\'

Also in the Discussion section, the following sentence should not have been included: 'In particular, our analyses provided nominally significant evidence of association of SNP rs11624702 in *MDGA2* with response in the combined ISPC-AMPS-STAR\*D meta-analysis.\'

[Supplementary Information](#sup1){ref-type="supplementary-material"} accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)

Supplementary Material {#sup1}
======================

###### 

Click here for additional data file.

![Manhattan plots showing genome-wide association results for the two outcome variables in the meta-analysis of ISPC, AMPS and STAR\*D data. (a) %Δ depression score, (b) response. AMPS, Antidepressant Medication Pharmacogenomics Study; ISPC, International SSRI Pharmacogenomics Consortium; STAR\*D, Sequenced Treatment Alternatives to Relieve Depression.](tp2016187f2){#fig2}

###### Top 10 association regions from the genome-wide association meta-analysis of the combined ISPC+AMPS sample and STAR\*D (all race)

  *Outcome measure*                 *SNP*      *CHR*     *BP*                *Gene*             *A1/A2*   *ISPC+AMPS (beta/OR)*   *STAR\*D (beta/OR)*   *Meta-analysis (beta/OR)*      P
  ----------------------------- ------------- ------- ----------- ---------------------------- --------- ----------------------- --------------------- --------------------------- ----------
  %Change in depression score    rs35806662      2     158790425    LOC100130766/UPP2/ACVR1       G/A             −0.18                  −0.21                    −0.20             6.47E−07
                                 rs73069924      5     32278233              MTMR12               G/A             −0.50                  −0.42                    −0.44             8.09E−07
                                  rs4615376      6     13071073             PHACTR1               G/A             −0.20                  −0.13                    −0.16             1.05E−06
                                  rs2566255     11      4605195         OR52I2/C11orf40           G/C             0.24                   0.26                     0.26              1.51E−06
                                  rs910039       6     17505944               CAP2                A/G             −0.10                  −0.17                    −0.13             2.11E−06
                                 rs17068112      6     139250125             REPS1                G/C             0.19                   0.37                     0.26              3.28E−06
                                  rs7485210     12     131638853   LOC116437/LINC01257/GPR133     A/C             0.18                   0.10                     0.14              3.42E−06
                                 rs74378198      5     38870908               OSMR                G/A             −0.69                  −0.37                    −0.43             3.77E−06
                                 rs10511037      3     74669078              CNTN3                G/A             −0.21                  −0.14                    −0.19             3.89E−06
                                  rs5904601     23     22016054             SMS/PHEX              C/T             0.15                   0.13                     0.14              4.24E−06
                                                                                                                                                                                        
  Response                       rs10954808      8     31479623               NRG1                G/A             0.73                   0.73                     0.73              1.20E−06
                                  rs2309896      9     73959235              TRPM3                C/T             0.33                   0.43                     0.38              3.26E−06
                                  rs674246      11     113141684             NCAM1                C/T             1.28                   1.38                     1.33              3.35E−06
                                 rs72772787      1     248016378             TRIM58               T/C             2.63                   1.94                     2.34              3.96E−06
                                  rs2540651     22     18972331              DGCR5                A/G             1.37                   1.28                     1.33              5.39E−06
                                  rs7051085     23     23374977              PTCHD1               A/T             0.60                   0.69                     0.63              5.51E−06
                                 rs11018318     10     128774073             DOCK1                A/G             1.30                   1.48                     1.38              6.17E−06
                                 rs74378198      5     38870908               OSMR                G/A             3.96                   2.19                     2.40              7.34E−06
                                  rs4759855     12     131640425           LOC116437              G/T             0.67                   0.67                     0.67              7.47E−06
                                 rs116842540     9     82367951               TLE4                T/A             0.36                   0.39                     0.37              7.67E−06

Abbreviations: AMPS, Antidepressant Medication Pharmacogenomics Study; Beta/OR, regression parameter estimates (beta) for SNP effect on quantitative trait outcome or odds ratio (OR) estimate for SNP effect on binary outcome; ISPC, International SSRI Pharmacogenomics Consortium; SNP, single-nucleotide polymorphism; STAR\*D, Sequenced Treatment Alternatives to Relieve Depression. There were other SNPs in these regions with suggestive evidence for association.

Note: Rather than showing results for multiple SNPs in one region, only one (top) SNP is shown for each association region.
